On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Istituto Biochimico Italiano Giovanni Lorenzini SpA's own share of each project, not the project's full budget.
- Horizon 2020€691k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- B-SMARTPartner
Brain-Specific, Modular and Active RNA Therapeutics
Horizon 2020 · 2017–2022 · Project on CORDIS ↗
€691ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 1 shared project
- Universitair Medisch Centrum UtrechtNetherlands · 1 shared project
- SINTEF ASNorway · 1 shared project
- Vib vzwBelgium · 1 shared project
- Universidad de Santiago de CompostelaSpain · 1 shared project
- Stiftelsen SINTEFNorway · 1 shared project
- Eurice European Research and Project Office GmbHGermany · 1 shared project
- Malvern Panalytical LimitedUnited Kingdom · 1 shared project
- 20med Therapeutics BVNetherlands · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- RNA
- alzheimer
- cell biology
- nano-materials
- nanomedicine
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.